2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow acipimox: new trials by email Literature Review of acipimox trials Research Report on acipimox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male Subjects KUC 7483 CL, Bisoprolol, Propranolol - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 12 | 2005-10-01 | 2014-10-06 |
| Free Fatty Acids and Vascular Function in Subjects With Diabetes acipimox, placebo - Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 40 | 2005-09-01 | 2018-09-25 |
Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1)
Boehringer Ingelheim (1) · Brigham and Women's Hospital (1)
United States (1)